News NHS trust league tables arrive in UK health shakeup League tables for NHS trusts will end the postcode lottery of care, says the government, but not all are convinced.
News FDA lends a hand to Novo, Lilly on illegal GLP-1 imports The FDA has set up a green list of overseas sources for GLP-1 ingredients to try to block imports of illegitimate and potentially unsafe materials.
News Massachusetts bucks HHS, issuing its own COVID guidelines The Bay State is the first to require insurers to cover the shot for everyone, despite conflicting guidance from RFK's HHS on who should get the jab.
News FDA releases previously unseen CRLs in transparency push The FDA's earlier decision to publish complete response letters was largely a repackaging of existing information, but now it has gone much further.
News RFK faces bipartisan pressure at fractious hearing In a three-hour hearing before the Finance Committee, Senators took RFK to task about CDC ousting and broken promises about the COVID-19 vaccine.
News Gilead, Amgen kick off facility investments in US This week saw both Gilead Sciences and Amgen start to fulfil pledges to step up capital investments in new US facilities.
News Otsuka grows in neuroplastogens with $1.225bn Transcend buy Otsuka has agreed to acquire Transcend Therapeutics and its MDMA-based neuroplastogen drug candidate for PTSD, heading for phase 3 trials.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
